SCHEMBL29616504

SCHEMBL29616504

O=C1CO[C@H]2CCN(C(=O)N3CCC(Cc4ccc(C(F)(F)F)cc4C(F)(F)F)CC3)C[C@H]2N1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 10/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23148914 1.00 MGLL (0.68) MGLL
SCHEMBL21730859 0.92 MGLL (0.69) MGLL
SCHEMBL21730787 0.91 MGLL (0.79) MGLL
SCHEMBL25785240 0.91 MGLL (0.79) MGLL
SCHEMBL21730857 0.90 MGLL (0.75) MGLL
SCHEMBL21730794 0.90 MGLL (0.66) MGLL
SCHEMBL21722985 0.88 MGLL (0.64) MGLL
SCHEMBL24095435 0.88 MGLL (0.67) MGLL
SCHEMBL22462769 0.88 MGLL (0.65) MGLL
SCHEMBL21730752 0.88 MGLL (0.64) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4034538-A1 NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-08-03 — — EP claimed
CN-114401968-A Novel heterocyclic monoacylglycerol lipase (MAGL) inhibitors 豪夫迈·罗氏有限公司 2022-04-26 — — CN claimed
EP-4034538-A1 NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-08-03 — — EP disclosed
CN-114401968-A Novel heterocyclic monoacylglycerol lipase (MAGL) inhibitors 豪夫迈·罗氏有限公司 2022-04-26 — — CN disclosed
Send feedback